NCT01967771 - Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG

DTG

DTG will be supplied as 50 mg tablet to be administered orally

DRUG

CBZ

CBZ will be supplied as 100 mg and 200 mg extended release tablet to be administered orally

Trial Locations (1)

GSK Investigational Site, Overland Park